Ireland· IE-PA-PA0822/195/001
Hypovase 0.5mg Tablets
A prazosin product containing prazosin, registered in Ireland by Pfizer Healthcare Ireland Unlimited Company. The same ATC class is registered in 9 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Prazosin is registered in 9 of 19 countries.
Countries holding a registration under ATC C02CA01 (prazosin), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 4 of them publish a price we can compare per daily dose
Prazosin · ATC C02CA01
9 / 19 countries
- Belgiumprice
- Canada
- Finlandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- United Kingdom
- United Statesprice
The record
At a glance
HPRA (Ireland)- Active substance
- Prazosin
- Manufacturer
- Pfizer Healthcare Ireland Unlimited Company
- Country
- Ireland (IE)
- ATC code
- C02CA01
- ATC class
- Prazosin
- Defined daily dose
- 5 mg, O
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberPA0822/195/001
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
98 interactions on record for prazosin.
Graded by severity as the source publishes them — 78 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Prazosin · interactions on record
98 records
- 78 moderate
- 20 info
Most severe, free to view
- ThiethylperazinA04AB03moderate
- DiphenhydraminA04AB05moderate
- DronabinolA04AD10moderate
- NabiloneA04AD11moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Prazosin in 8 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomHypovase 500microgram tabletsPfizer Ltd
- United StatesPrazosinLannett Company, Inc.
- FinlandPatsolinSchering Oy
- NorwayAlpress LPPfizer
- CanadaAPO-PRAZOAPOTEX INC
- BelgiumMinipress 1 mgPfizer
- SpainMINIPRES 1 mg COMPRIMIDOSPfizer S.L.
- FranceALPRESS L.P. 2,5 mg, comprimé osmotique à libération prolongéePFIZER HOLDING FRANCE
Authorised across Europe · EMA
The same active substance is authorised in 5 EEA countries. Names it is sold under:
- Cyprus · Atodel
- Spain · Minipres
- Finland · Pratsiol
- France · Alpress L.P.
- United Kingdom (Northern Ireland) · Hypovase
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/42be9b52-0ec2-4130-8372-1db6dbaa4ea1 GET /v1/drugs/42be9b52-0ec2-4130-8372-1db6dbaa4ea1?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tablet",
"routes": [
"Oral use"
],
"source": "hpra",
"atc_all": [
"C02CA",
"C02CA01"
],
"strength": null,
"pa_number": "PA0822/195/001",
"substances": [
"Prazosin"
],
"legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
"market_info": "Marketed",
"authorised_at": "01/04/1979",
"dispensing_status": "Product subject to prescription which may be renewed (B)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about prazosin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.